Free Trial

Trevi Therapeutics (TRVI) SEC Filings & 10K Form

Trevi Therapeutics logo
$6.26 -0.03 (-0.40%)
As of 01:02 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Trevi Therapeutics SEC Filings

DateFilerForm TypeView
05/15/2025
8:55 AM
Frazier Life Sciences Public Fund, L.P. (Filed by)
Trevi Therapeutics (Subject)
Form SCHEDULE 13G/A
04/29/2025
9:14 AM
Trevi Therapeutics (Filer)
Form DEF 14A
04/29/2025
9:22 AM
Trevi Therapeutics (Filer)
Form ARS
03/26/2025
3:30 PM
SCIASCIA THOMAS (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2025
3:30 PM
GOOD JENNIFER L (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
6:55 PM
New Enterprise Associates 16, L.P. (Filed by)
Trevi Therapeutics (Subject)
Form SCHEDULE 13D/A
03/18/2025
3:16 PM
Trevi Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/18/2025
3:10 PM
Trevi Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2025
4:03 PM
Trevi Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2025
3:32 PM
Simon Farrell (Reporting)
Trevi Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
5:04 PM
Trevi Therapeutics (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
Form SCHEDULE 13G/A
02/14/2025
10:21 AM
Frazier Life Sciences Public Fund, L.P. (Filed by)
Trevi Therapeutics (Subject)
Form SCHEDULE 13G/A
02/13/2025
12:41 PM
Rosalind Advisors, Inc. (Filed by)
Trevi Therapeutics (Subject)
Form SCHEDULE 13G/A
01/08/2025
7:00 AM
Trevi Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2024
3:30 PM
Galletta Christopher (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
4:20 PM
Trevi Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2024
4:18 PM
Trevi Therapeutics (Filer)
Form 424B5
12/12/2024
7:00 AM
Trevi Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2024
4:20 PM
Trevi Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
4:51 PM
Trevi Therapeutics (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
Form SC 13G/A
11/13/2024
3:30 PM
Rubric Capital Management LP (Filed by)
Trevi Therapeutics (Subject)
Form SC 13G/A
11/08/2024
5:57 PM
New Enterprise Associates 16, L.P. (Filed by)
Trevi Therapeutics (Subject)
Form SC 13D/A
11/06/2024
3:20 PM
Trevi Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
9:30 AM
Frazier Life Sciences Public Fund, L.P. (Filed by)
Trevi Therapeutics (Subject)
Form SC 13G/A
10/23/2024
1:44 PM
Rosalind Advisors, Inc. (Filed by)
Trevi Therapeutics (Subject)
Form SC 13G/A
10/21/2024
9:43 AM
Trevi Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
7:07 AM
Trevi Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
4:00 PM
GOOD JENNIFER L (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
3:54 PM
GOOD JENNIFER L (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
3:37 PM
GOOD JENNIFER L (Reporting)
Trevi Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/29/2024
3:55 PM
Meeker David P (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
3:10 PM
Meeker David P (Reporting)
Trevi Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/15/2024
4:14 PM
SCIASCIA THOMAS (Reporting)
Trevi Therapeutics (Subject)
Form 144/A
07/11/2024
4:52 PM
Rosalind Advisors, Inc. (Filed by)
Trevi Therapeutics (Subject)
Form SC 13G/A
07/10/2024
3:16 PM
MAI Capital Management (Filed by)
Trevi Therapeutics (Subject)
Form SCHEDULE 13G/A
06/14/2024
3:40 PM
Mathers Edward T (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:30 PM
Colangelo Dominick (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:30 PM
Trevi Therapeutics (Issuer)
VANLENT ANNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:30 PM
Meeker David P (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:30 PM
Heffernan Michael Thomas (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:30 PM
Cassella James V (Reporting)
Trevi Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
July 2025 Rule Change to Impact Retirement Investors (Ad)

There's a massive change from a new rule going into effect this July. And it's one the Big Banks are already using to their advantage… It allows them to treat this new asset like actual cash.

Yes, Send Me My FREE Retirement Guide
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:TRVI) was last updated on 5/27/2025 by MarketBeat.com Staff
From Our Partners